Subscribe
Facebook Twitter Instagram Youtube

Rwanda Organisation fighting against hepatitis (ROFAH)

Email

rofah13@gmail.com

Phone

T: +250 788519484

Address

Prince House BuildingN5 Road”, Gasabo, Remera, PO Box 4473 Kigali Rwanda 4473 Rwanda
About Rwanda Organisation fighting against hepatitis (ROFAH)

Vision:
ROFAH’s vision is to contribute in promoting health of Rwandans through improved access to Hepatitis disease’s prevention, treatment, care and support programs, therefore contribute to eradicate the Hepatitis in Rwanda.

Mission:
ROFAH has the mission of improving life and health of its members, relatives and other direct beneficiaries through specific programs of fighting against Hepatitis in Rwanda.

Core values:

  • Solidarity and collective actions in Fighting Hepatitis and promoting palliative care as well psychosocial support to people having and or affected by Hepatitis
  • Active participation and involvement of members, government institutions, DPs and other stakeholders in ROFAH programs implementation;
  • Ensuring and maintaining credibility, reliability, integrity, accountability and transparency in all operations;
  • Ensure gender mainstreaming and human rights in all activities;
  • Use of rights, evidences and results based approaches in all related Hepatitis program.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)
Confirm consent(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close